dpp-4 inhibitor and glp-1 receptor agonist combination not recommended ada Neuroprotection by dipeptidyl-peptidase-4 inhibitors glucagon-like peptide-1 analogs via the modulation of AKT-signaling pathway in Alzheimer's disease Frontiers | DPP-4 inhibitors for

[1] Healthcare providers may need to adjust the dosages of these concomitant medications to mitigate the risk of hypoglycemia

Vesiculopustular dermatosis: an uncommon side-effect of liraglutide

Common side effects of Saxenda include nausea, diarrhea, constipation, vomiting, injection site reaction, low blood sugar, headache, fatigue, dizziness, stomach pain, and changes in enzyme levels in the blood

Because prospective endpoint studies comprising large patient populations had just been published for saxagliptin (The Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus [SAVOR]Thrombolysis in Myocardial Infarction [TIMI] 53 trial [SAVOR-TIMI 53]